Keep up to date with the latest news from Accelagen
Delivering a Data-Driven Future at Accelagen: Meet Janus and Jessie
Spotlighting our Data Management team—meet Janus Rowlan D. Relos and Jessie Lourdesamy, as they drive innovation and excellence in clinical data solutions.
Why Regulatory Affairs is the Backbone of Accelagen’s Expertise: Introducing Our Newest Regulatory Affairs Officers, Adriana Paola Camargo
As we expand our Regulatory Affairs team, learn how Accelagen is enhancing expertise in regulatory strategy, market authorisation, and patient impact.
New Faces, New Frontiers: Meet Accelagen’s Newest Clinical Project Managers
Introducing two of Accelagen’s new Clinical Project Managers, driving innovation in rare disease and global clinical trials.
Welcoming Ano Chinogurei as Accelagen’s People & Culture Lead
Learn how Accelagen’s new Head of People & Culture, Ano Chinogurei, is shaping a people-first culture, and leveraging tech to drive growth & engagement.
How Accelagen’s Medical Team is elevating clinical trial excellence
How Accelagen’s Medical Team is elevating clinical trial excellence Accelagen’s medical team is growing, strengthening our capabilities in pharmacovigilance, medical writing, and clinical oversight for safer, smarter trials.Accelagen is in an exciting phase of growth, with our medical team expanding…
Leading the future of Biostatistics at Accelagen: Meet our experienced new Head of Biostatistics, Rebecca Asher
Leading the future of Biostatistics at Accelagen: Meet our experienced new Head of Biostatistics, Rebecca Asher Australia’s biotech sector is growing rapidly, and Accelagen is proud to be leading the way. Meet our experienced new Head of Biostatistics, Rebecca Asher.Behind…
The people powering progress: Meet Accelagen’s latest CRA recruits
Meet some of Accelagen’s newest CRAs—passionate, driven and ready to make a real-world impact. Get to know the team shaping the future of clinical research.
Accelerating Equity: Women in Biotech and creating an inclusive workplace culture
Accelerating Equity: Women in Biotech and Creating an Inclusive Workplace Culture With nearly 70% of its workforce being women, Accelagen is redefining biotech by fostering equity, flexibility, and career growth in STEM.Despite some progress, women remain underrepresented in leadership roles…
Putting people first: Dr. Eleanor Guest joins Accelagen’s Executive Leadership Team
Putting people first: Dr. Eleanor Guest joins Accelagen’s Executive Leadership Team Accelagen welcomes Dr. Eleanor Guest as Executive Director of Operations, bringing 14+ years of clinical research expertise to drive growth and innovation.As a CRO, our work is paved by milestones—and…